Suppr超能文献

胰腺伴有破骨细胞样巨细胞的未分化癌的细胞学特征及临床意义:15例分析

Cytologic features and clinical implications of undifferentiated carcinoma with osteoclastic giant cells of the pancreas: An analysis of 15 cases.

作者信息

Reid Michelle D, Muraki Takashi, HooKim Kim, Memis Bahar, Graham Rondell P, Allende Daniela, Shi Jiaqi, Schaeffer David F, Singh Remmi, Basturk Olca, Adsay Volkan

机构信息

Department of Pathology, Emory University Hospital, Atlanta, Georgia.

Department of Pathology, Thomas Jefferson University, Philadelphia, Pennsylvania.

出版信息

Cancer Cytopathol. 2017 Jul;125(7):563-575. doi: 10.1002/cncy.21859. Epub 2017 Apr 3.

Abstract

BACKGROUND

The cytologic features of undifferentiated pancreatic carcinoma with osteoclastic giant cells (UOC) are rarely described.

METHODS

Cytologic and clinicopathologic characteristics in 15 UOC fine-needle aspiration (FNA) specimens were analyzed.

RESULTS

FNA specimens were obtained from 6 men and 8 women with a mean age of 65 years who had UOCs (head, n = 7; body, n = 3; and tail, n = 4) with a mean radiologic size 7.3 cm, and some had a cystic component (n = 9). Three cell types (osteoclastic giant cells, pleomorphic tumor giant cells, and spindled/histiocytoid cells) were observed in 12 of 15 specimens (80%); and pancreatic ductal adenocarcinoma (PDAC) was present in 11 specimens. FNA diagnoses were UOC (n = 6), PDAC (n = 5), poorly differentiated carcinoma (n = 2), "suspicious for neoplasm" (n = 1), and "negative" (n = 1). Five of 5 specimens with osteoclastic giant cells were positive for cluster of differentiation 68 (CD68) (a glycoprotein that binds to low-density lipoprotein). Pleomorphic tumor giant cells and spindled/histiocytoid cells were positive for pancytokeratin (6 of 7 specimens), CAM5.2 (2 of 3 specimens), and epithelial membrane antigen (2 of 2 specimens). INI-1 protein expression was retained in 3 of 3 specimens. The Ki-67 labeling index was assessed in 3 specimens and was 12%, 18%, and 40%; 4 of 12 resected UOCs were pure, and 8 were mixed with PDAC. One resection specimen had intraductal papillary mucinous neoplasm, and 2 had mucinous cystic neoplasms. The median overall survival (OS) of patients who had UOCs identified on FNA was 8 months (6 died [OS, 8 months; range, 2-22 months], and 8 remained alive [OS, 3 months; range, 1-27 months]), which was similar to the survival of 74 patients who had PDACs identified on FNA (OS, 15 months; P = .279) but worse than that of the 27 patients with UOCs who did not undergo FNA (OS, 92 months; P = .0135).

CONCLUSIONS

The 3 classical UOC cell types are identifiable on FNA, making cytologic diagnosis possible if considered in the differential. A PDAC component is often also observed. The survival advantage of UOC over pure PDAC appears to be negated by FNA and requires further investigation. Cancer Cytopathol 2017;125:563-75. © 2017 American Cancer Society.

摘要

背景

具有破骨细胞样巨细胞的未分化胰腺癌(UOC)的细胞学特征鲜有描述。

方法

分析15例UOC细针穿刺(FNA)标本的细胞学和临床病理特征。

结果

FNA标本取自6名男性和8名女性,平均年龄65岁,患有UOC(胰头,n = 7;胰体,n = 3;胰尾,n = 4),平均影像学大小7.3 cm,部分有囊性成分(n = 9)。15例标本中的12例(80%)观察到三种细胞类型(破骨细胞样巨细胞、多形性肿瘤巨细胞和梭形/组织细胞样细胞);11例标本存在胰腺导管腺癌(PDAC)。FNA诊断为UOC(n = 6)、PDAC(n = 5)、低分化癌(n = 2)、“肿瘤可疑”(n = 1)和“阴性”(n = 1)。5例含破骨细胞样巨细胞的标本中,5例分化簇68(CD68,一种与低密度脂蛋白结合的糖蛋白)呈阳性。多形性肿瘤巨细胞和梭形/组织细胞样细胞对全细胞角蛋白(7例标本中的6例)、CAM5.2(3例标本中的2例)和上皮膜抗原(2例标本中的2例)呈阳性。3例标本中INI-1蛋白表达均保留。对3例标本评估Ki-67标记指数,分别为12%、18%和40%;12例切除的UOC中,4例为纯合型,8例与PDAC混合。1例切除标本有导管内乳头状黏液性肿瘤,2例有黏液性囊性肿瘤。FNA确诊为UOC的患者中位总生存期(OS)为8个月(6例死亡[OS,8个月;范围,2 - 22个月],8例存活[OS,3个月;范围,1 - 27个月]),这与FNA确诊为PDAC的74例患者的生存期(OS,15个月;P = 0.279)相似,但比27例未接受FNA的UOC患者的生存期(OS,92个月;P = 0.0135)差。

结论

FNA可识别3种典型的UOC细胞类型,若在鉴别诊断中考虑到,则可进行细胞学诊断。通常也观察到PDAC成分。FNA似乎消除了UOC相对于纯PDAC的生存优势,这需要进一步研究。《癌症细胞病理学》2017年;125:563 - 75。©2017美国癌症协会

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验